ArticleFrontiers in pharmacology2026

Early disease control with a biochemical response to aumolertinib after postoperative recurrence of EGFR-Mutant stage IIIA lung adenocarcinoma after icotinib, with EGFR T790M detected at recurrence: a Case Report.

Zhenyu Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.